Velabs collaborates with Chiome for GPCR-Specific functional antibody screening

Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, announced that it has ent...

April 24, 2019 | Wednesday | News
LifeArc licenses lead stage molecules to Daiichi Sankyo

LifeArc, one of the UK’s leading medical research charities, has signed a deal to license an ion channel drug disc...

April 24, 2019 | Wednesday | News
Eisai selected as a Competitive IT Strategy Company 2019

Eisai Co has been selected by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE)...

April 24, 2019 | Wednesday | News
ACT Genomics to provide cancer genomic profiling service

ACTmed, a joint venture between Canon Medical Systems Corporation and ACT Genomics, has established an analysis laborato...

April 21, 2019 | Sunday | News
Nagasaki University, NEC initiate program on Global Health

Nagasaki University and NEC Corporation have established a program on global health & biometric authentication with ...

April 18, 2019 | Thursday | News
Quantum dot imaging advances

Investigations of 'quantum dots' for looking deeply into body tissues are rapidly evolving, but more work is required to...

April 17, 2019 | Wednesday | News
Fujifilm and Kyoto University jointly developed AI-based diagnostic support technology

FUJIFILM and Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University (Professor Toyohiro Hirai...

April 16, 2019 | Tuesday | News
Permobil to launch its new F-Series in Japan

Permobil, a global leader in advanced rehabilitation technology, has updated its successful modular front wheel dri...

April 16, 2019 | Tuesday | News
Daiichi Sankyo launches Tarlige Tablets for pain treatment in Japan

Daiichi Sankyo has announced the launch of Tarlige® Tablets 2.5 mg, 5 mg, 10 mg, 15 mg (generic name: mirogabal...

April 15, 2019 | Monday | News
Shionogi licenses Symproic to BioDelivery Sciences International Inc.

Shionogi, Japanese major research-driven pharmaceutical company dedicated to bringing benefits to patients has anno...

April 11, 2019 | Thursday | News
Kaken Pharma, HitGen to develop a novel class of drugs

HitGen has announced that HitGen Inc. and Kaken Pharmaceutical have entered into a license agreement to develop a n...

April 12, 2019 | Friday | News
EdiGene raises $15 M in Series B funding

EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for the treatment of genetic disorders ...

April 11, 2019 | Thursday | News
Japan approves Rakuten Medical's ASP-1929 to treat cancer

Based on its exclusive license related to photoimmunotherapy, Rakuten Medical Inc., which is developing a cancer therapy...

April 10, 2019 | Wednesday | News
GeneDesign joins Ajinomoto Bio-pharma

Ajinomoto Bio-Pharma, a leading provider of biopharmaceutical contract development and manufacturing services has a...

April 9, 2019 | Tuesday | News
Japan grants Sakigake designation to Eisai’s novel FGFR

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...

April 8, 2019 | Monday | News
Clinigen K.K., GC Pharma sign pact to market Hunterase ICV

Clinigen K.K. and GC Pharma have recently announced an exclusive licensing agreement in Japan to commercialize...

April 5, 2019 | Friday | News
Japan approves first drug for ADA deficiency

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has acqui...

April 4, 2019 | Thursday | News
Takeda takes step towards EU Entyvio extension

Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...

April 2, 2019 | Tuesday | News